Integer Holdings Corporation
$89.32
▲
0.47%
2026-04-21 07:36:01
www.integer.net
NYQ: ITGR
Explore Integer Holdings Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.07 B
Current Price
$89.32
52W High / Low
$127.56 / $62
Stock P/E
29.89
Book Value
$50.85
Dividend Yield
—
ROCE
7.52%
ROE
6.11%
Face Value
—
EPS
$2.89
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
11,000
Beta
0.71
Debt / Equity
75.44
Current Ratio
3.32
Quick Ratio
2.23
Forward P/E
11.78
Price / Sales
1.58
Enterprise Value
$4.23 B
EV / EBITDA
11.21
EV / Revenue
2.28
Rating
Buy
Target Price
$93.25
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
| 2. | Accuray Incorporated | $0.46 | — | $52.79 M | — | 2.82% | -70.32% | $2.1 / $0.33 | $0.45 |
| 3. | Autonomix Medical, Inc. | $0.4 | — | $4.63 M | — | -143.08% | -1.89% | $2.82 / $0.34 | $0.75 |
| 4. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 5. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 6. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 7. | Senseonics Holdings, Inc. | $6.87 | — | $287.13 M | — | -67.05% | -1.68% | $15.74 / $5.25 | $1.48 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 472.06 M | 467.69 M | 476.49 M | 437.39 M | 449.5 M | — |
| Operating Profit | 54.55 M | 65.9 M | 62.9 M | 55.79 M | 56.12 M | — |
| Net Profit | 48.61 M | 39.68 M | 37.01 M | -22.49 M | 32.7 M | — |
| EPS in Rs | 1.43 | 1.16 | 1.09 | -0.66 | 0.96 | 0.99 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.85 B | 1.72 B | 1.56 B | 1.33 B |
| Operating Profit | 239.14 M | 220.39 M | 174.75 M | 127.95 M |
| Net Profit | 102.81 M | 119.9 M | 90.65 M | 66.38 M |
| EPS in Rs | 3.02 | 3.52 | 2.66 | 1.95 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 3.41 B | 3.08 B | 2.94 B | 2.79 B |
| Total Liabilities | 1.66 B | 1.46 B | 1.42 B | 1.38 B |
| Equity | 1.75 B | 1.62 B | 1.52 B | 1.42 B |
| Current Assets | 770.1 M | 671.12 M | 617.67 M | 558.3 M |
| Current Liabilities | 232.04 M | 227.17 M | 220.97 M | 223.75 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 196.15 M | 205.21 M | 180.21 M | 116.38 M |
| Investing CF | -270.73 M | -195.41 M | -163.37 M | -200.42 M |
| Financing CF | 43.56 M | 13.32 M | -18.01 M | 92.48 M |
| Free CF | 105.12 M | 99.85 M | 60.27 M | 41.65 M |
| Capex | -91.03 M | -105.36 M | -119.94 M | -74.73 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 10.35% | 16.85% | — | — |
| Earnings Growth % | 32.26% | 36.57% | — | — |
| Profit Margin % | 6.98% | 5.83% | 4.99% | — |
| Operating Margin % | 12.84% | 11.23% | 9.61% | — |
| Gross Margin % | 26.74% | 26.35% | 25.97% | — |
| EBITDA Margin % | 18.11% | 16.42% | 14.87% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.